Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

Whole body retention of I-131 at 24hr vs 48hr as a predictor of maximum tolerated activity (MTA)

Frank Atkins, Douglas Van Nostrand, Michael Orquiza and Leonard Wartofsky
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1857;
Frank Atkins
1Div Nuclear Medicine, MedStar Washington Hospital Center, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas Van Nostrand
1Div Nuclear Medicine, MedStar Washington Hospital Center, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Orquiza
1Div Nuclear Medicine, MedStar Washington Hospital Center, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonard Wartofsky
2Dept Medicine, MedStar Washington Hospital Center, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1857

Objectives To evaluate the reliability and robustness of a single measurement at 24hr post administration of I-131 of fractional whole body retention (WBR) as a predictor of MTA.

Methods Previously we reported on a bi-exponential model (Thyroid 2009 19(10):1093-98) for estimating the maximum tolerated activity (MTA) of I-131 for the treatment of metastatic, well-differentiated thyroid cancer (WDTC) based on a limit of 2 Gy to the blood. This model incorporates the patient’s body surface area (BSA) along with the fractional whole body retention (%WBR) of a diagnostic dosage of I-131 at 48 hrs post oral administration to estimate the MTA. The advantage of the 24hr time point, if reliable, is it might allow an extension of this model based on the %WBR at 48hr to instead be used with I-123 and an earlier time point, which is typically used for pre-therapy imaging. Since Mar 2011 all patients (n=99) undergoing dosimetry also had their %WBR calculated at 24hr post administration of approx 74 MBq of I-131. These patients were prepared for their anticipated radioiodine therapy for WDTC either by thyroid hormone withdrawal (n=41) or rhTSH (n=58).

Results A very good correlation exists between the WBR at 24hr and 48hr (r=0.96). When the iodine clearance is relatively rapid (%WBR @ 24hr < 35%) it can also be a good predictor of the MTA (r=0.88). Over this range of %WBR none of the patients (n=52) had a measured MTA which was < 80% of the estimated value based solely on the %WBR. This is more often the case for rhTSH compared to THW where the median values for the %WBR at 24hr were 28.9% and 41.8%, respectively. For patients with less rapid clearance the variability is too great and a second delayed measurement would be warranted.

Conclusions The WBR at 24hr using I-123 could potentially be used in a predictive model of the MTA for the majority of patients provided this value is < 35%. Otherwise a delayed measurement at 48hr might be necessary.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Whole body retention of I-131 at 24hr vs 48hr as a predictor of maximum tolerated activity (MTA)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Whole body retention of I-131 at 24hr vs 48hr as a predictor of maximum tolerated activity (MTA)
Frank Atkins, Douglas Van Nostrand, Michael Orquiza, Leonard Wartofsky
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1857;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Whole body retention of I-131 at 24hr vs 48hr as a predictor of maximum tolerated activity (MTA)
Frank Atkins, Douglas Van Nostrand, Michael Orquiza, Leonard Wartofsky
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1857;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties

  • COMMON PEDIATRIC NUCLEAR MEDICINE IMAGING STUDIES: A COMPREHENSIVE REVIEW
  • COVID-19 and Nuclear Medicine: what we know so far…
  • Utility of Depth Correction Calculator for Split Renal Function Studies utilizing prior CT or MRI
Show more General Clinical Specialties

MTA II: Endocrine/Neuroendocrine Posters

  • SPECT-CT and differentiated thyroid carcinoma
  • A semi-quantitative analysis of pathological 68Ga-DOTATATE PET/CT uptake by primary site dependent neuroendocrine tumor metastases
  • Enhanced localization of posteriorly-descending superior parathyroid adenomas by SPECT
Show more MTA II: Endocrine/Neuroendocrine Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire